These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 7982238)
1. Prognostic prediction in neuroblastomas: clinical significance of combined analysis for Ha-ras p21 expression and N-myc gene amplification. Tanaka T; Seeger RC; Tanabe M; Hiyama E; Shimoda H; Ida N Cancer Detect Prev; 1994; 18(4):283-9. PubMed ID: 7982238 [TBL] [Abstract][Full Text] [Related]
2. Expressions of N-myc and ras oncogene products in neuroblastoma and their correlations with prognosis. Nakada K; Fujioka T; Kitagawa H; Takakuwa T; Yamate N Jpn J Clin Oncol; 1993 Jun; 23(3):149-55. PubMed ID: 8350488 [TBL] [Abstract][Full Text] [Related]
3. [Tumor markers--personal experience. Ha-ras P21 in neuroblastoma: a new marker associating to patient's prognosis]. Tanaka T Gan To Kagaku Ryoho; 1991 Jan; 18(1):143-50. PubMed ID: 1987897 [TBL] [Abstract][Full Text] [Related]
4. Ha-ras p21 in neuroblastoma: a new marker in prediction of patient outcome. Tanaka T Prog Clin Biol Res; 1994; 385():275-80. PubMed ID: 7972221 [No Abstract] [Full Text] [Related]
5. Expression of N-myc and c-src protooncogenes correlating to the undifferentiated phenotype and prognosis of primary neuroblastomas. Matsunaga T; Takahashi H; Ohnuma N; Tanabe M; Yoshida H; Iwai J; Shirasawa H; Simizu B Cancer Res; 1991 Jun; 51(12):3148-52. PubMed ID: 2039993 [TBL] [Abstract][Full Text] [Related]
6. Lack of correlation of N-myc gene amplification with prognosis in localized neuroblastoma: a Pediatric Oncology Group study. Cohn SL; Look AT; Joshi VV; Holbrook T; Salwen H; Chagnovich D; Chesler L; Rowe ST; Valentine MB; Komuro H Cancer Res; 1995 Feb; 55(4):721-6. PubMed ID: 7850780 [TBL] [Abstract][Full Text] [Related]
7. Expression of Ha-ras oncogene products in human neuroblastomas and the significant correlation with a patient's prognosis. Tanaka T; Slamon DJ; Shimoda H; Waki C; Kawaguchi Y; Tanaka Y; Ida N Cancer Res; 1988 Feb; 48(4):1030-4. PubMed ID: 3276397 [TBL] [Abstract][Full Text] [Related]
9. Inverse correlation between expression of multidrug resistance gene and N-myc oncogene in human neuroblastomas. Nakagawara A; Kadomatsu K; Sato S; Kohno K; Takano H; Akazawa K; Nose Y; Kuwano M Cancer Res; 1990 May; 50(10):3043-7. PubMed ID: 2185879 [TBL] [Abstract][Full Text] [Related]
10. N-myc amplification and cell proliferation rate in human neuroblastoma. Pession A; Trerè D; Perri P; Rondelli R; Montanaro L; Mantovani W; Derenzini M; Paolucci G J Pathol; 1997 Nov; 183(3):339-44. PubMed ID: 9422991 [TBL] [Abstract][Full Text] [Related]
11. myc gene amplification and expression in primary human neuroblastoma. Slavc I; Ellenbogen R; Jung WH; Vawter GF; Kretschmar C; Grier H; Korf BR Cancer Res; 1990 Mar; 50(5):1459-63. PubMed ID: 2302711 [TBL] [Abstract][Full Text] [Related]
12. Surgical aspects of N-myc oncogene amplification of neuroblastoma. Nakagawara A; Ikeda K; Yokoyama T; Tsuda T; Higashi K Surgery; 1988 Jul; 104(1):34-40. PubMed ID: 3388178 [TBL] [Abstract][Full Text] [Related]
13. MYCN protein expression as a predictor of neuroblastoma prognosis. Chan HS; Gallie BL; DeBoer G; Haddad G; Ikegaki N; Dimitroulakos J; Yeger H; Ling V Clin Cancer Res; 1997 Oct; 3(10):1699-706. PubMed ID: 9815553 [TBL] [Abstract][Full Text] [Related]
14. Detection of n-myc gene amplification in neuroblastoma by comparative, in situ,and real-time polymerase chain reaction. Melegh Z; Bálint I; Tóth E; Csernák E; Szentirmay Z; Nagy K Pediatr Pathol Mol Med; 2003; 22(3):213-22. PubMed ID: 12746172 [TBL] [Abstract][Full Text] [Related]
16. Investigation of co-amplification of the candidate genes ornithine decarboxylase, ribonucleotide reductase, syndecan-1 and a DEAD box gene, DDX1, with N-myc in neuroblastoma. United Kingdom Children's Cancer Study Group. George RE; Kenyon RM; McGuckin AG; Malcolm AJ; Pearson AD; Lunec J Oncogene; 1996 Apr; 12(7):1583-7. PubMed ID: 8622876 [TBL] [Abstract][Full Text] [Related]
17. Amplification of N-myc as a prognostic marker for patients with neuroblastoma. Schwab M Semin Cancer Biol; 1993 Feb; 4(1):13-8. PubMed ID: 8448374 [TBL] [Abstract][Full Text] [Related]
18. Expression of the apoptosis-suppressing protein bcl-2, in neuroblastoma is associated with unfavorable histology and N-myc amplification. Castle VP; Heidelberger KP; Bromberg J; Ou X; Dole M; Nuñez G Am J Pathol; 1993 Dec; 143(6):1543-50. PubMed ID: 8256847 [TBL] [Abstract][Full Text] [Related]
19. Inverse relationship between trk expression and N-myc amplification in human neuroblastomas. Nakagawara A; Arima M; Azar CG; Scavarda NJ; Brodeur GM Cancer Res; 1992 Mar; 52(5):1364-8. PubMed ID: 1737399 [TBL] [Abstract][Full Text] [Related]
20. Expression of B-myb in neuroblastoma tumors is a poor prognostic factor independent from MYCN amplification. Raschellà G; Cesi V; Amendola R; Negroni A; Tanno B; Altavista P; Tonini GP; De Bernardi B; Calabretta B Cancer Res; 1999 Jul; 59(14):3365-8. PubMed ID: 10416595 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]